Medicis Pharmaceutical Corporation (MRX)
Medicis Pharmaceutical Corporation Cash and ST Investments: 342.28M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MRX Cash and ST Investments Rankings
| Overall | 75th percentile | 1051 of 4371 |
| Sector | 84th percentile | 77 of 504 in Healthcare |
| Industry | 85th percentile | 2 of 14 in Drugs - Generic |
MRX Cash and ST Investments Range, Past 5 Years
| Minimum | 288.32M | Dec 2011 |
| Maximum | 805.76M | Jun 2011 |
| Average | 566.50M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these MRX related companies
MRX News
$MRX Mentioned more than normal on StockTwits - Currently at 8 x average daily social activity
about 5 days ago by TradeIdeasQuant
about 5 days ago by TradeIdeasQuant
Barclays on U.S. Specialty Pharmaceuticals: Model Updates on FRX, MRX, WCRX & PCRX
May 25, 12:32PM Street Insider
May 25, 12:32PM Street Insider
Goldman Calls Medicis (MRX) 'One of the Most Likely M&A Targets' in Specialty Pharma Space
May 25, 11:38AM Street Insider
May 25, 11:38AM Street Insider
Cantor Fitzgerald Maintains a 'Hold' on Medicis (MRX); Looking For The Accretive Transaction
May 14, 9:53AM Street Insider
May 14, 9:53AM Street Insider
Medicis to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 14, 8:00AM GlobeNewswire
May 14, 8:00AM GlobeNewswire
Auriga Reiterates a 'Buy' on Medicis (MRX); Q1 Beat Underscores Execution
May 10, 1:46PM Street Insider
May 10, 1:46PM Street Insider
Listen to $MRX First Quarter 2012 Medicis Earnings Conference Call - live at 05:15 PM, ondemand after - http://stks.co/3jQK
about 22 days ago by earningscast
about 22 days ago by earningscast
$MRX made 7k off this stock and peeved because i couldnt raise my sell price quick enough!
about 22 days ago by strategymizer
about 22 days ago by strategymizer
RT @TheEquitiesRoom Notables trading down to 50d MA: $ADS $MRX $VFC $CSTR $CHMT $WOOF $KLIC
about 24 days ago by HuberMarketNote
about 24 days ago by HuberMarketNote
Needham & Company Reiterates a 'Buy' on Solta Medical (SLTM); Good Quarter
May 02, 9:20AM Street Insider
May 02, 9:20AM Street Insider
Cantor Fitzgerald Maintains a 'Hold' on Medicis (MRX); Adjusting Numbers
Apr 19, 8:45AM Street Insider
Apr 19, 8:45AM Street Insider
$MRX setting up for the next leg higher. http://chart.ly/ltstspt
about 42 days ago by AffluenzaVirus
about 42 days ago by AffluenzaVirus
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Klz
about 47 days ago by MarketBrief
about 47 days ago by MarketBrief
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3IZ5
about 49 days ago by MarketBrief
about 49 days ago by MarketBrief
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3HIW
about 51 days ago by MarketBrief
about 51 days ago by MarketBrief
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3GLH
about 52 days ago by MarketBrief
about 52 days ago by MarketBrief
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3FPR
about 54 days ago by MarketBrief
about 54 days ago by MarketBrief
Deutsche Bank Maintains a 'Buy' on Medicis (MRX) After In-Depth Meeting with Management
Apr 05, 9:56AM Street Insider
Apr 05, 9:56AM Street Insider
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3EQY
about 55 days ago by MarketBrief
about 55 days ago by MarketBrief
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3DKL
about 56 days ago by MarketBrief
about 56 days ago by MarketBrief
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MRX | 36.73 | -0.35 | -0.94% | 2.185B |
| MRVL | 12.74 | -0.31 | -2.38% | 7.647B |
| MRO | 24.86 | -0.66 | -2.59% | 17.97B |
| MRNAD | 0.7203 | -0.09 | -11.07% | |
| MRNA | 0.7389 | +0.02 | +2.58% | 5.842M |
| MRLN | 13.98 | -0.39 | -2.71% | 182.64M |
| MRK | 37.41 | -0.18 | -0.48% | 114.42B |
| MRH | 20.44 | -0.10 | -0.49% | 1.219B |
| MRGE | 2.40 | -0.08 | -3.23% | 225.70M |
| MRF | 7.84 | -0.06 | -0.76% |